The Gut Punch Weekly #2Metsera’s long-acting GLP-1 shows promise, Trump’s Greenland feud threatens Novo, Lilly and Novo seek to restrict GLP-1 compounding, and more.The Gut PunchJan 08, 2025∙ Paid2ShareContinue reading this post for free, courtesy of The Gut Punch.Claim my free postOr purchase a paid subscription.PreviousNext
